·
3 Min Read

Court ruling in CVS-Aetna merger leaves patients unprotected

Judicial decision ultimately fails patients.

Press Releases
·
3 Min Read

July 25, 2019: Advocacy spotlight on Scrutiny of CVS-Aetna deal shows AMA's powerful impact

The scrutiny of CVS-Aetna deal shows AMA's powerful impact on the health care system. Learn more.

Advocacy Update
·
2 Min Read

AMA statement on closing arguments in CVS-Aetna case

The CVS-Aetna merger and divestiture are not in the public interest, and the court should refuse to approve the antitrust settlement proposed by the DOJ.

Press Releases
Man in pharmacy looking at a prescription
·
3 Min Read

Scrutiny of CVS-Aetna deal shows AMA’s powerful impact

The AMA has led opposition to the anti-competitive $69 billion mega-merger. Closing arguments in the matter take place in federal court tomorrow.

Access to Care
·
2 Min Read

July 12, 2019: State Advocacy Update

Closing arguments in the CVS/Aetna case in the latest AMA state advocacy news.

Advocacy Update
·
3 Min Read

June 14, 2019: Advocacy spotlight on CVS-Aetna merger: Not yet a final deal—AMA outlines competitive harm

The CVS-Aetna merger: Not yet a final deal. Find out how AMA outlines competitive harm.

Advocacy Update
·
2 Min Read

AMA on court review of $69B CVS-Aetna merger settlement

The AMA has concluded that a merger of these two rivals would harm competition and patients, even with the divestiture proposed in the merger settlement.

Press Releases
Man in pharmacy looking at medicine bottle.
·
3 Min Read

What’s at stake in this week’s CVS-Aetna merger hearing 

Unprecedented federal court hearing on $70 billion deal demonstrates AMA’s effectiveness in challenging the anticompetitive consolidation of certain health care markets.  

Judicial Advocacy
·
6 Min Read

Dec. 13, 2018: National Advocacy Update

Choice and competition in health care, new drug pricing rule for Part D drugs and more in AMA's national advocacy news.

Advocacy Update